Hangzhou Tigermed Consulting Co., Ltd
HNGZY
$3.96
-$0.1386-3.38%
OTC PK
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 9.98% | -21.01% | |||
| Total Other Revenue | -- | 305.30% | |||
| Total Revenue | 0.74% | -10.60% | |||
| Cost of Revenue | -14.21% | 17.10% | |||
| Gross Profit | 69.58% | -57.21% | |||
| SG&A Expenses | 4.97% | -3.91% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -3,020.85% | -101.63% | |||
| Total Operating Expenses | -11.68% | 13.27% | |||
| Operating Income | 1,041.48% | -105.36% | |||
| Income Before Tax | 133.61% | -205.94% | |||
| Income Tax Expenses | 1.75% | -36.70% | |||
| Earnings from Continuing Operations | 123.89% | -231.13% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 16.71% | 287.35% | |||
| Net Income | 140.08% | -226.75% | |||
| EBIT | 1,041.48% | -105.36% | |||
| EBITDA | 586.47% | -91.64% | |||
| EPS Basic | 139.37% | -228.24% | |||
| Normalized Basic EPS | 141.90% | -65.00% | |||
| EPS Diluted | 139.37% | -228.24% | |||
| Normalized Diluted EPS | 141.90% | -65.00% | |||
| Average Basic Shares Outstanding | 1.73% | -1.23% | |||
| Average Diluted Shares Outstanding | 1.73% | -1.23% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | 3.01% | -1.05% | |||